Latest Insights - page 38 | BiopharmaTrend

Proscia Raises $50M to Expand AI Pathology Platform and Precision Medicine Tools

Proscia, a developer of AI-based pathology software, has raised $50 million in funding, bringing its total capital raised to $130 million. The funding round was led by Insight Partners, with …

Continue ›››

Synchron and NVIDIA Collaborate on Real-Time Neural Processing for BCIs

Synchron, a developer of implantable brain-computer interface (BCI) technology, has announced a collaboration with NVIDIA to enhance its next-generation BCI using the NVIDIA Holoscan platform. The partnership, announced at the …

Continue ›››

Sofinnova Raises €165M to Back European Biotech Startups

Sofinnova Partners, a European life sciences venture capital firm, has closed its Biovelocita II fund at €165 million, surpassing its original target. The fund attracted backing from major pharmaceutical companies, …

Continue ›››

Researchers Develop AI Tool that Maps Cellular "Social Networks" to Guide Cancer Treatment

Researchers have developed a new artificial intelligence (AI) tool that can analyze how cells communicate within tissues, potentially guiding more personalized treatments for cancer and other diseases. The tool, called …

Continue ›››

UK Company Secures £600,000 for 3D Lung Model to Replace Animal Testing

ImmuONE, a UK-based biotech company developing a 3D human lung model for drug and chemical testing, has secured £600,000 in follow-on funding from the Midlands Engine Investment Fund, Mercia Ventures, …

Continue ›››

Next Generation Sequencing: New Tech and Companies to Watch

From the discovery of the double helix to the latest AI-driven innovations. In this article: Roche’s NGS Trajectory — Sequencing History — NGS in Healthcare — Notable Recent NGS Events — …

Continue ›››

Elsevier Launches ScienceDirect AI to Provide Summarized Research Insights

Elsevier launched ScienceDirect AI, a new generative AI tool designed to help researchers quickly access and summarize key findings from millions of peer-reviewed research articles and book chapters. The tool, …

Continue ›››

Tempus Acquires AI-Powered Clinical Trial Matching Platform

Tempus AI has announced the acquisition of a clinical trial matching platform Deep 6 AI, which applies artificial intelligence (AI) to streamline patient recruitment and real-world evidence generation. The acquisition adds …

Continue ›››

Insilico Medicine Raises $110M to Advance AI Drug Design, Unveils its Humanoid Lab Robot

Insilico Medicine has raised $110 million in Series E funding to support clinical trials and further develop its AI-driven drug discovery programs. The round was led by Hong Kong‑based Value …

Continue ›››

Lila Sciences Raises $200M to Automate Scientific Discovery with AI and Robotics

Flagship Pioneering has announced the launch of Lila Sciences, a company developing an AI-based platform designed to automate scientific experimentation and discovery. Lila’s platform combines generative AI with autonomous lab …

Continue ›››

Creation Healthcare Launches Platform to Analyze Global Social Media Discourse Among Healthcare Professionals

Creation Healthcare has launched HCP Voice, a real-time analytics platform built to track and interpret the social media conversations of millions of healthcare professionals (HCPs) worldwide. The platform provides pharmaceutical …

Continue ›››

AI-Powered Immune Mapping Company Appoints Ex-Pfizer R&D Chief to Its Board

Immunai has appointed Mikael Dolsten, M.D., Ph.D., former Chief Scientific Officer and President of Research & Development at Pfizer, to its Board of Directors. Dolsten spent 15 years at Pfizer, …

Continue ›››